CD4 and neoplasm: Whether high levels of tumor-infiltrating T lymphocytes (both CD3+CD8+ and CD3+CD4+) in TME have long been recognized to have a favorable prognostic role [77,78], emerging insight into T cell biology indicates that the rescue of T cell homing at the tumor site is also essential for ICI efficacy.